as on February 10, 2026 at 7:59 am IST
Day's Low
Day's High
2.12%
Downside
0.79%
Upside
52 Week's Low
52 Week's High
6.61%
Downside
133.33%
Upside
Check Precision Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$97.2M
EPS (TTM)
-6.1633
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
4.5
Industry PE ratio
-2.8179250720461093
PEG Ratio
0EBITDA
-87.9M
Revenue (TTM)
698.0K
Profit Margin
0.00%
Return On Equity TTM
-205.16%
Track how Precision Biosciences Inc P/E has moved over time to understand its valuation trends.
Precision Biosciences Inc in the last 5 years
Lowest (-184.25x)
March 31, 2021
Industry (-2.82x)
February 9, 2026
Today (4.50x)
February 9, 2026
Highest (61.99x)
June 30, 2024
Today’s Price to Earnings Ratio: 4.50x
Compare market cap, revenue, PE, and other key metrics of Precision Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $97.2M | -99.13% | 4.5 | 0.00% |
The Precision Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Precision Biosciences Inc investment value today
Current value as on today
₹84,133
Returns
Returns from Precision Biosciences Inc Stock
Dollar Returns*
₹3,707 (+3.71%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Precision Biosciences Inc. Average target price of $32.5
Get share price movements and forecasts by analysts on Precision Biosciences Inc.
What analysts predicted
88.37%UPSIDE
Target Price
$32.5
Current Price
$3.78
Analyzed by
12 Analysts
Target
$32.50
Precision Biosciences Inc target price $32.5, a slight upside of 88.37% compared to current price of $3.78. According to 12 analysts rating.
Search interest for Precision Biosciences Inc Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 07 October
Tue, 07:22 PM
-Precision BioSciences opens first U.S. clinical trial site for the Eliminate-B trial, focusing on gene editing therapies.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 83.48 Cr → 173.52 Cr (in ₹), with an average increase of 30.6% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -23.52M → -21.77M (in $), with an average increase of 8.0% per quarter
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -42.12 Cr → 21.16 Cr (in ₹), with an average increase of 212.9% per quarter
Against Peers
![]()
In the last 3 years, Avanti Feeds Ltd has given 164.8% return, outperforming this stock by 199.2%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 29.11% of holdings in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 68.90% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 44.8% return, outperforming this stock by 133.4%
Against Peers
![]()
In the last 1 year, Avanti Feeds Ltd has given 38.0% return, outperforming this stock by 72.5%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 61.1% return, outperforming this stock by 81.8%
Revenue Fall
![]()
Revenue is down for the last 4 quarters, 638.0K → 13.0K (in $), with an average decrease of 53.7% per quarter
Price Dip
![]()
In the last 7 days, DTIL stock has moved down by -2.0%
Price Dip
![]()
In the last 3 years, DTIL stock has moved down by -88.6%
| Organisation | Precision Biosciences Inc |
| Headquarters | 302 East Pettigrew St., Durham, NC, United States, 27701 |
| Industry | Biotechnology |
| CEO | Mr. Michael Amoroso |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Michael Amoroso | President, CEO & Director |
Mr. John Alexander Kelly R.Ph. | CFO & Principal Accounting Officer |
Dr. Cassie Gorsuch Ph.D. | Chief Scientific Officer |
Ms. Juli Blanche | Chief People Officer |
Mr. Neil Leatherbury M.S. | Senior VP and Head of Chemistry, Manufacturing & Controls |
Dr. Jefferson J. Smith Ph.D. | Co-Founder & Chief Research Officer |
Mr. Naresh Tanna | Chief of Staff to CEO & Head of Investor Relations |
Mr. Dario Scimeca J.D. | General Counsel & Secretary |
Ms. Cindy Atwell | Chief Development & Business Officer |
Precision Biosciences Inc share price today is $3.78 as on at the close of the market. Precision Biosciences Inc share today touched a day high of $3.81 and a low of $3.7.
Precision Biosciences Inc share touched a 52 week high of $8.82 on and a 52 week low of $3.53 on . Precision Biosciences Inc stock price today i.e. is closed at $3.78,which is 57.14% down from its 52 week high and 7.08% up from its 52 week low.
Precision Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Precision Biosciences Inc (DTIL) shares with as little as ₹90.717 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹907.17 in Precision Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Precision Biosciences Inc share’s latest price of $3.78 as on February 10, 2026 at 2:29 am IST, you will get 2.6455 shares of Precision Biosciences Inc. Learn more about
fractional shares .
Precision Biosciences Inc stock has given -99.13% share price returns and 24.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?